Challenges in the Assessment of Medical Devices: The MedtecHTA Project.

Assessing medical devices (MDs) raises challenges which require us to reflect on whether current methods are adequate. Major features of devices are: (i) device-operator interaction can generate learning curve effects; (ii) incremental nature of innovation needs to be addressed by careful identification of the alternatives for comparative and incremental cost-effectiveness analysis; and (iii) broader organizational impact in terms of training and infrastructure, coupled with dynamic pricing, requires a more flexible approach to costing. The objective of the MedtecHTA project was to investigate improvements in HTA methods to allow for more comprehensive evaluation of MDs. It consisted of several work packages concerning (i) the available evidence on the currently adopted approaches for regulation and HTA of medical devices; (ii) the geographical variation in access to MDs; (iii) the development of methodological frameworks for conducting comparative effectiveness research and economic evaluation of MDs; and (iv) the organizational impact of MDs. This introductory paper summarizes the main results of the project and draws out the main overarching themes. This supplement represents a comprehensive report of all the main findings of the MedtecHTA project, and it is intended to be the main source for researchers and policy makers wanting information on the project. © 2017 The Authors. Health Economics published by John Wiley & Sons, Ltd.

[1]  Claire Rothery,et al.  Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs. , 2017, Health economics.

[2]  Deborah Cohen,et al.  Europeans are left to their own devices , 2011, BMJ : British Medical Journal.

[3]  G. Boriani,et al.  Expenditure and value for money: the challenge of implantable cardioverter defibrillators. , 2009, QJM : monthly journal of the Association of Physicians.

[4]  Mike Drummond,et al.  Generating appropriate clinical data for value assessment of medical devices: what role does regulation play? , 2014, Expert review of pharmacoeconomics & outcomes research.

[5]  Uwe Siebert,et al.  Ten recommendations for assessing the comparative effectiveness of therapeutic medical devices: a targeted review and adaptation. , 2017, Journal of clinical epidemiology.

[6]  Michael Drummond,et al.  Economic evaluation for devices and drugs--same or different? , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[7]  M. Drummond,et al.  Challenges in the clinical and economic evaluation of medical devices: The case of transcatheter aortic valve implantation , 2011 .

[8]  Yauheniya Varabyova,et al.  The Role of Learning in Health Technology Assessments: An Empirical Assessment of Endovascular Aneurysm Repairs in German Hospitals. , 2017, Health economics.

[9]  Corinna Sorenson,et al.  Applying health economics for policy decision making: do devices differ from drugs? , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  Rosanna Tarricone,et al.  Improving the Methods for the Economic Evaluation of Medical Devices. , 2017, Health economics.

[11]  Jonas Schreyögg,et al.  Balancing adoption and affordability of medical devices in Europe. , 2009, Health policy.

[12]  Oriana Ciani,et al.  Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments. , 2017, Health economics.

[13]  G. Boriani,et al.  Implant rates of cardiac implantable electrical devices in Europe: A systematic literature review. , 2016, Health policy.

[14]  Carl Rudolf Blankart,et al.  Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey. , 2017, Health economics.

[15]  Oriana Ciani,et al.  HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES , 2015, International Journal of Technology Assessment in Health Care.

[16]  G. Boriani,et al.  Health economics and outcomes research: a new challenge and field of action for the European Heart Rhythm Association. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  Aleksandra Torbica,et al.  Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences? , 2017, Health economics.

[18]  Cynthia P Iglesias,et al.  Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  Cynthia P Iglesias,et al.  A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement. , 2017, Health economics.

[20]  M. Krucoff,et al.  Commentary: International collaboration needed on device clinical standards , 2011, BMJ : British Medical Journal.

[21]  G. Boriani,et al.  Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  Michael Drummond,et al.  Key Recommendations from the MedtecHTA Project. , 2017, Health economics.